AHPI Allied Healthcare Products Inc

ST. LOUIS, Nov. 14 /PRNewswire-FirstCall/ -- Allied Healthcare Products, Inc. (NASDAQ:AHPI) reported that its net income fell about 57 percent in the first quarter ending September 30, from about $202,000 last year, or 3 cents per share, to $87,000 in the current period, or 1 cent per share. Sales for the period declined about 2.8 percent, from about $14.5 million last year to $14.1 million this year. Shipments were depressed somewhat in the quarter by short-term production difficulties but these issues have been resolved, the company said. Despite sales weakness in some product areas in the quarter, Allied President and Chief Executive Officer Earl Refsland said that he expected stronger results to help the company meet its objectives for fiscal 2008. Refsland also said that Food and Drug Administration approval of a new product for the emergency preparedness market has taken longer than expected but should be received before the end of 2007. Allied again improved its cash position, Refsland said. The company had a cash balance of more than $4.0 million at the end of the quarter, an increase of about 10 percent over the previous quarter. Allied Healthcare Products, Inc. is a leading manufacturer of respiratory care products, medical gas equipment and emergency medical products used in a wide range of alternate care settings. "SAFE HARBOR" STATEMENT: Statements contained in this release that are not historical facts or information are "forward-looking statements." Words such as "believe," "expect," "intend," "will," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward- looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made. ALLIED HEALTHCARE PRODUCTS, INC. CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED) Three months ended September 30, 2007 2006 Net sales $14,101,618 $14,477,442 Cost of sales 10,934,605 10,957,890 Gross profit 3,167,013 3,519,552 Selling, general and administrative expenses 3,042,969 3,190,997 Income from operations 124,044 328,555 Interest income (40,769) (28,169) Other expense, net 15,150 9,302 (25,619) (18,867) Income before provision for income taxes 149,663 347,422 Provision for income taxes 62,597 145,788 Net income $87,066 $201,634 Basic and diluted earnings per share $0.01 $0.03 Weighted average common shares Outstanding - Basic 7,883,577 7,859,903 Weighted average common shares Outstanding - Diluted 8,106,796 8,065,153 ALLIED HEALTHCARE PRODUCTS, INC. CONSOLIDATED BALANCE SHEET (UNAUDITED) September 30, 2007 June 30, 2007 ASSETS Current assets: Cash and cash equivalents $4,017,496 $3,638,870 Accounts receivable, net of allowances of $325,000 and $460,000, respectively 7,395,812 7,251,767 Inventories, net 12,195,312 12,999,472 Other current assets 619,244 275,254 Total current assets 24,227,864 24,165,363 Property, plant and equipment, net 10,422,347 10,677,000 Goodwill 15,979,830 15,979,830 Other assets, net 565,221 496,127 Total assets $51,195,262 $51,318,320 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $3,010,398 $3,040,313 Other accrued liabilities 2,684,800 2,508,820 Deferred income taxes 734,531 882,001 Deferred revenue 465,000 465,000 Total current liabilities 6,894,729 6,896,134 Deferred revenue 1,821,250 1,937,500 Commitments and contingencies Stockholders' equity: Preferred stock; $0.01 par value; 1,500,000 shares authorized; no shares issued and outstanding - - Series A preferred stock; $0.01 par value; 200,000 shares authorized; no shares issued and outstanding - - Common stock; $0.01 par value; 30,000,000 shares authorized; 10,187,069 shares issued at September 30, 2007 and June 30, 2007; 7,883,577 shares outstanding at September 30, 2007 and June 30, 2007 101,871 101,871 Additional paid-in capital 47,459,837 47,441,163 Retained earnings 15,649,003 15,673,080 Less: treasury stock, at cost; 2,303,492 shares at September 30, 2007 and June 30, 2007 (20,731,428) (20,731,428) Total stockholders' equity 42,479,283 42,484,686 Total liabilities and stockholders' equity $51,195,262 $51,318,320 DATASOURCE: Allied Healthcare Products, Inc. CONTACT: Daniel C. Dunn, Chief Financial Officer of Allied Healthcare Products, Inc., +1-314-771-2400 Web site: http://www.alliedhpi.com/

Copyright